Can a smart app improve MS care? new study seeks answers

NCT ID NCT05949580

Recruiting now Knowledge-focused Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 31 times

Summary

This study is testing a new digital platform designed to help doctors and patients track multiple sclerosis (MS) over time. About 500 people with relapsing-remitting MS and their healthcare providers will use the platform for two years. The goal is to see if the tool is easy to use and if it improves how MS is monitored in everyday medical practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSING REMITTING MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hackensack University Medical Center
RECRUITING

Hackensack, New Jersey, 07601, United States
Jersey Shore University Medical Centre
RECRUITING

Neptune City, New Jersey, 07753, United States
Minneapolis Clinic of Neurology
RECRUITING

Golden Valley, Minnesota, 55422, United States
Praxis Dr. med. Max Deist und Michael Ernst ?Sinsheim
RECRUITING

Sinsheim, 74889, Germany
Universitaetsklinikum Carl Gustav Carus an der TU Dresden
RECRUITING

Dresden, 01307, Germany

Conditions

Explore the condition pages connected to this study.

RELAPSING REMITTING MULTIPLE SCLEROSIS